Registration
GREENWICH BIOSCIENCES, INC. for GREENWICH BIOSCIENCES, INC.
Client
Income
—
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Pharmaceutical manufacturing and Healthcare
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALICE P. MEAD New | Vice President, U.S. Professional Relations |
Health Issues HCR
Pharmaceutical manufacturing and Healthcare
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALICE P. MEAD New | Vice President, U.S. Professional Relations |
Medicare/Medicaid MMM
Pharmaceutical manufacturing and Healthcare
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALICE P. MEAD New | Vice President, U.S. Professional Relations |
Insurance INS
Pharmaceutical manufacturing and Healthcare
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALICE P. MEAD New | Vice President, U.S. Professional Relations |
Pharmacy PHA
Pharmaceutical manufacturing and Healthcare
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALICE P. MEAD New | Vice President, U.S. Professional Relations |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| GW PHARMACEUTICALS PLC | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.